219 related articles for article (PubMed ID: 22540862)
21. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
22. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer.
Mattar R; Alves de Andrade CR; DiFavero GM; Gama-Rodrigues JJ; Laudanna AA
Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(3):89-92. PubMed ID: 12118264
[TBL] [Abstract][Full Text] [Related]
23. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
[TBL] [Abstract][Full Text] [Related]
24. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
[TBL] [Abstract][Full Text] [Related]
25. Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases.
Zhou YC; Zhao HJ; Shen LZ
Asian Pac J Cancer Prev; 2015; 16(7):2685-91. PubMed ID: 25854347
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
[TBL] [Abstract][Full Text] [Related]
28. Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer.
Marrelli D; Pinto E; De Stefano A; de Manzoni G; Farnetani M; Garosi L; Roviello F
J Surg Oncol; 2001 Dec; 78(4):253-8. PubMed ID: 11745820
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
31. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
[TBL] [Abstract][Full Text] [Related]
32. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
[TBL] [Abstract][Full Text] [Related]
34. Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
Gwak HK; Lee JH; Park SG
Asian Pac J Cancer Prev; 2014; 15(12):4933-8. PubMed ID: 24998567
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.
Marrelli D; Roviello F; De Stefano A; Farnetani M; Garosi L; Messano A; Pinto E
Oncology; 1999 Jul; 57(1):55-62. PubMed ID: 10394126
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy.
Zhang YH; Li Y; Chen C; Peng CW
Hepatogastroenterology; 2009; 56(96):1750-4. PubMed ID: 20214231
[TBL] [Abstract][Full Text] [Related]
39. [The role of tumor markers in diagnosing metastases of gastric cancer: preoperative diagnostics (part I)].
Kurygin AA; Maĭstrenko NA; Khrykov GN; Beliak NP
Vestn Khir Im I I Grek; 2009; 168(4):16-9. PubMed ID: 19947409
[TBL] [Abstract][Full Text] [Related]
40. High Expression of Serum UCA1 may be a Potential Biomarker for Clinical Diagnosis of Gastric Cancer.
Shan L; Liu C; Ma C
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]